High phosphorous intake associated with increased risk of lethal prostate cancer
the ONA take:
According to a new study published in the American Journal of Clinical Nutrition, phosphorous is independently associated with the risk of developing lethal and high-grade prostate cancer.
Researchers identified nearly 48,000 men who reported their diet in 1986 and every 4 years thereafter. During the 24-year follow-up, 5,861 participants developed prostate cancer, 789 of which were lethal cancers. Results showed phosphorous intake was linked with a greater risk for developing prostate cancer, including lethal and high-grade disease.
This association was independent of calcium and dairy, fish, red meat, and white meat intake. In addition, high calcium intake was associated with an elevated risk for developing advanced-stage and high-grade disease 12 to 16 years after exposure.
High phosphorous intake was linked with an increased risk for developing advanced-stage and high-grade prostate cancer 0 to 8 years after exposure. Foods high in phosphorous include: seeds, lentils, cheese, colas, shellfish, and yogurt.
Phosphorous is independently associated with the risk of developing lethal and high-grade prostate cancer.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|